🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

UPDATE 3-FTSE 100 helped by weak pound; New COVID-19 restrictions hit consumer stocks

Published 09/09/2020, 04:59 PM
Updated 09/10/2020, 12:10 AM
© Reuters.
UK100
-
LLOY
-
AZN
-
JDW
-
RTN
-
MARS
-
FTMC
-
FTNMX405010
-

* AstraZeneca pauses trials of coronavirus vaccine
* England bans gatherings of more than six people
* No-deal Brexit fears send pound to six-week low

(Adds details, updates to market close)
By Shashank Nayar and Ambar Warrick
Sept 9 (Reuters) - London's blue-chip index ended higher on
Wednesday as weakness in the pound looked to benefit major
exporters, while the mid-cap index was held back by consumer
stocks on fears of new restrictions on social activity.
The FTSE 100 .FTSE ended 1.4% higher as uncertainty over
Brexit talks weighed on the pound. Stocks such as British
American Tobacco BATS.L and Unilever ULVR.L , which make a
bulk of their revenue overseas, were the biggest boosts to the
index.
The midcap index .FTMC ended 0.2% lower, with consumer
discretionary stocks weighing the most as Prime Minister Boris
Johnson announced new restrictions on social gatherings in
England to tackle a surge in COVID-19 cases. Pub and restaurant owners including J D Wetherspoon Plc
JDW.L , Marston's Plc MARS.L and Restaurant Group Plc RTN.L
fell between 8% and 11%, while the domestic travel and leisure
index .FTNMX5750 lost 1.4%.
"The new social restrictions have led to some panic selling,
especially in some restaurant and pub stocks, with the
possibility of further downfall if more draconian restrictions
are imposed," said Keith Temperton, a sales trader at Forte
Securities.
AstraZeneca Plc AZN.L recovered from initial losses,
ending marginally higher on a report that it could resume trials
for its experimental coronavirus vaccine next week. The firm had
paused trials of the vaccine after an unexplained illness in a
participant. Its peer Glaxosmithkline GSK.L , which is also developing a
vaccine, rose 2.7%.
Hopes for vaccines and treatments to address the pandemic
have helped lift global equity benchmarks after a crash earlier
this year.
But British stocks have lagged their peers in the developed
world as resurgent infections and middling economic data cut
short an initial bounce from March lows.
In company news, shares in Britain's biggest domestic bank
Lloyds LLOY.L were flat as it said it was making 865
redundancies, with lenders resuming cost-cutting measures to
ride out the impact of the pandemic.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.